Pharma Campaign Cash Delivered to Key Lawmakers With Surgical Precision
With an eye to shutting down Medicare drug price negotiations, drug companies and their lobbying groups gave roughly $1.6 million in the first six months of 2021, with Democrats edging closer than they have in a decade to Republicans’ total haul.
Community Clinics Shouldered Much of the Vaccine Rollout. Many Haven’t Been Paid.
Federally qualified health centers from California to Michigan are mired in a bureaucratic mess over how they should be paid under Medicaid for each dose of covid vaccine given. In California alone, clinics await reimbursement for at least 1 million shots, causing a “massive cash flow problem.”
Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief
The Food and Drug Administration has been mired in controversies related to drug approvals and covid vaccines, all without a permanent leader.
To Quarantine or Not: The Hard Choices Schools Are Leaving to Parents and Staff
Back-to-school season has fueled immediate covid outbreaks. Instead of beefing up protections, some districts are letting students go without masks, physical distancing and quarantines. And parents are left to make impossibly tough decisions.
What Missouri Learned the Hard Way About Rapid Covid Testing in Schools
Missouri’s ambitious school testing plan landed with a thud. What it can teach us now about keeping the delta variant out of classrooms.
‘We Sent a Terrible Message’: Scientists Say Biden Jumped the Gun With Vaccine Booster Plan
Many experts say the evidence doesn’t justify widespread booster shots for adults.
At Urgent Care, He Got 5 Stitches and a Big Surprise: A Plastic Surgeon’s Bill for $1,040
The Biden administration is weighing how to treat urgent care clinics as part of broad regulations banning surprise, out-of-network medical bills. At the heart of the matter: What counts as an emergency?
Novavax’s Effort to Vaccinate the World, From Zero to Not Quite Warp Speed
Novavax is a vaccine company that has never licensed a vaccine. It hopes it can still help to fight the global covid scourge, but can it get doses made worldwide?
Unused Johnson & Johnson Covid Doses Are Piling Up as FDA Waits to See if Shelf Life Can Be Extended
As vaccine expiration dates loom, states with hundreds of thousands of doses on hand say demand is tanking and there’s no easy way to donate to other states or countries that might want them
Stark Racial Disparities Persist in Vaccinations, State-Level CDC Data Shows
Black Americans’ vaccination rates still trail all other groups, while Hispanics show improvement. Native Americans show the strongest rates nationally.